Swift RM - Search Results

1

Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.

Kenna GA, McGeary JE, Swift RM. Kenna GA, et al. Among authors: swift rm. Am J Health Syst Pharm. 2004 Nov 15;61(22):2380-8. doi: 10.1093/ajhp/61.22.2380. Am J Health Syst Pharm. 2004. PMID: 15581261 Review.

2

Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism.

Swift RM, Duncan D, Nirenberg T, Femino J. Swift RM, et al. J Addict Dis. 1998;17(3):35-47. doi: 10.1300/J069v17n03_04. J Addict Dis. 1998. PMID: 9789158

3

The DRD4 VNTR polymorphism moderates craving after alcohol consumption.

Hutchison KE, McGeary J, Smolen A, Bryan A, Swift RM. Hutchison KE, et al. Among authors: swift rm. Health Psychol. 2002 Mar;21(2):139-46. Health Psychol. 2002. PMID: 11950104 Clinical Trial.

4

Topiramate for the treatment of alcohol dependence: initiating abstinence.

Swift RM. Swift RM. Lancet. 2003 May 17;361(9370):1666-7. doi: 10.1016/S0140-6736(03)13378-8. Lancet. 2003. PMID: 12767727 No abstract available.

5

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction.

Hutchison KE, Wooden A, Swift RM, Smolen A, McGeary J, Adler L, Paris L. Hutchison KE, et al. Among authors: swift rm. Neuropsychopharmacology. 2003 Oct;28(10):1882-8. doi: 10.1038/sj.npp.1300264. Neuropsychopharmacology. 2003. PMID: 12888781 Clinical Trial.

6

Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.

Kenna GA, McGeary JE, Swift RM. Kenna GA, et al. Among authors: swift rm. Am J Health Syst Pharm. 2004 Nov 1;61(21):2272-9. doi: 10.1093/ajhp/61.21.2272. Am J Health Syst Pharm. 2004. PMID: 15552634 Review.

7

Pharmacotherapy of dual substance abuse and dependence.

Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM. Kenna GA, et al. Among authors: swift rm. CNS Drugs. 2007;21(3):213-37. doi: 10.2165/00023210-200721030-00003. CNS Drugs. 2007. PMID: 17338593 Review.

8

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.

Tidey JW, Monti PM, Rohsenow DJ, Gwaltney CJ, Miranda R Jr, McGeary JE, MacKillop J, Swift RM, Abrams DB, Shiffman S, Paty JA. Tidey JW, et al. Among authors: swift rm. Alcohol Clin Exp Res. 2008 Jan;32(1):58-66. doi: 10.1111/j.1530-0277.2007.00545.x. Epub 2007 Nov 20. Alcohol Clin Exp Res. 2008. PMID: 18028530 Free PMC article.

9

New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications.

Leggio L, Kenna GA, Swift RM. Leggio L, et al. Among authors: swift rm. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1106-17. doi: 10.1016/j.pnpbp.2007.09.021. Epub 2007 Oct 4. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18029075 Review.

10

Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.

Leggio L, Ferrulli A, Cardone S, Miceli A, Kenna GA, Gasbarrini G, Swift RM, Addolorato G. Leggio L, et al. Among authors: swift rm. Alcohol. 2008 Aug;42(5):375-81. doi: 10.1016/j.alcohol.2008.03.128. Epub 2008 May 16. Alcohol. 2008. PMID: 18486430 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters